BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-24 |
|---|---|---|---|---|
| 2023 | $66.53 | $57.99 | $82.14 | -26.68% |
| 2024 | $64.63 | $60.41 | $69.76 | -28.78% |
| 2025 | $65.88 | $59.41 | $72.77 | -27.4% |
| 2026 | $64.75 | $57.19 | $73.01 | -28.65% |
| 2027 | $64.62 | $57.62 | $72.42 | -28.78% |
| 2028 | $64.69 | $57.99 | $72.57 | -28.7% |
| 2029 | $64.9 | $58.6 | $72.72 | -28.48% |
| 2030 | $64.98 | $58.1 | $72.6 | -28.38% |
| 2031 | $65.19 | $58.3 | $72.29 | -28.16% |
| 2032 | $65.3 | $57.91 | $72.62 | -28.04% |
| 2033 | $65.73 | $59.53 | $71.84 | -27.56% |
The 23 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$111.22 with a high forecast of $132.0 and a low forecast of $74.0.
The average BioMarin Pharmaceutical stock forecast represents a 22.57%
increase from the last price of $90.7399978637695.
From AI system, total return is 2366.52% from 4098 forecasts.
For BioMarin Pharmaceutical stock forecast for 2023, 9 predictions are offered for each month of 2023 with average BioMarin Pharmaceutical stock
forecast of $66.53, a high forecast of $82.14, and a low forecast of $57.99.
The average BioMarin Pharmaceutical stock forecast 2023 represents a -26.68%
decrease from the last price of $90.7399978637695.
For BioMarin Pharmaceutical stock forecast for 2024, 12 predictions are offered for each month of 2024 with average BioMarin Pharmaceutical stock
forecast of $64.63, a high forecast of $69.76, and a low forecast of $60.41.
The average BioMarin Pharmaceutical stock forecast 2024 represents a -28.78%
decrease from the last price of $90.7399978637695.
For BioMarin Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $64.75, a high forecast of $73.01, and a low forecast of $57.19.
The average BioMarin Pharmaceutical stock forecast 2026 represents a -28.65%
decrease from the last price of $90.7399978637695.
For BioMarin Pharmaceutical stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average BioMarin Pharmaceutical stock
forecast of $64.69, a high forecast of $72.57, and a low forecast of $57.99.
The average BioMarin Pharmaceutical stock forecast 2028 represents a -28.7%
decrease from the last price of $90.7399978637695.
For BioMarin Pharmaceutical stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $65.19, a high forecast of $72.29, and a low forecast of $58.3.
The average BioMarin Pharmaceutical stock forecast 2031 represents a -28.16%
decrease from the last price of $90.7399978637695.
For BioMarin Pharmaceutical stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average BioMarin Pharmaceutical stock
forecast of $65.73, a high forecast of $71.84, and a low forecast of $59.53.
The average BioMarin Pharmaceutical stock forecast 2033 represents a -27.56%
decrease from the last price of $90.7399978637695.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $111.22, and this show a 4.31% increase in average from the prior price target of the each prediction. Also, this average forecast of $111.22 represents a 1.41% increase from the past average forecast of $109.67, 6 months ago from 9 wall street analysts.
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-27 | $98.43 | 8.48% |
| 2023-03-28 | $106.55 | 8.25% |
| 2023-03-29 | $111.73 | 4.86% |
| 2023-03-30 | $109.95 | -1.59% |
| 2023-03-31 | $108.08 | -1.70% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $82.14 , for 2024 Mar. is $62.42 , for 2027 Mar. is $57.62 , for 2028 Mar. is $60.16 , for 2032 Mar. is $72.26 , and for 2033 Mar. is $71.84.
BMRN : BioMarin Pharmaceutical stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $82.14 | -9.48% |
| 2023 May. | $73.86 | -10.08% |
| 2023 Jun. | $67.59 | -8.49% |
| 2023 Jul. | $63.32 | -6.31% |
| 2023 Aug. | $59.97 | -5.30% |
| 2023 Sep. | $57.99 | -3.30% |
| 2023 Oct. | $59.50 | 2.61% |
| 2023 Nov. | $64.82 | 8.93% |
| 2023 Dec. | $69.56 | 7.31% |
BMRN : BioMarin Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $69.76 | 0.30% |
| 2024 Feb. | $66.47 | -4.72% |
| 2024 Mar. | $62.42 | -6.08% |
| 2024 Apr. | $60.41 | -3.23% |
| 2024 May. | $62.23 | 3.02% |
| 2024 Jun. | $66.06 | 6.15% |
| 2024 Jul. | $67.88 | 2.76% |
| 2024 Aug. | $65.58 | -3.39% |
| 2024 Sep. | $61.79 | -5.78% |
| 2024 Oct. | $60.51 | -2.07% |
| 2024 Nov. | $63.81 | 5.45% |
| 2024 Dec. | $68.60 | 7.51% |
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $69.30 | 1.03% |
| 2025 Feb. | $64.54 | -6.87% |
| 2025 Mar. | $60.17 | -6.77% |
| 2025 Apr. | $61.80 | 2.70% |
| 2025 May. | $67.84 | 9.78% |
| 2025 Jun. | $70.60 | 4.06% |
| 2025 Jul. | $66.56 | -5.73% |
| 2025 Aug. | $60.83 | -8.61% |
| 2025 Sep. | $59.41 | -2.33% |
| 2025 Oct. | $65.36 | 10.02% |
| 2025 Nov. | $72.77 | 11.34% |
| 2025 Dec. | $71.39 | -1.90% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $64.80 | -9.22% |
| 2026 Feb. | $58.51 | -9.72% |
| 2026 Mar. | $57.22 | -2.20% |
| 2026 Apr. | $63.95 | 11.77% |
| 2026 May. | $72.10 | 12.75% |
| 2026 Jun. | $73.01 | 1.26% |
| 2026 Jul. | $65.99 | -9.62% |
| 2026 Aug. | $59.28 | -10.16% |
| 2026 Sep. | $57.19 | -3.53% |
| 2026 Oct. | $62.41 | 9.13% |
| 2026 Nov. | $69.49 | 11.34% |
| 2026 Dec. | $72.98 | 5.03% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $68.24 | -6.51% |
| 2027 Feb. | $61.62 | -9.69% |
| 2027 Mar. | $57.62 | -6.49% |
| 2027 Apr. | $60.34 | 4.72% |
| 2027 May. | $67.10 | 11.19% |
| 2027 Jun. | $72.42 | 7.94% |
| 2027 Jul. | $70.28 | -2.96% |
| 2027 Aug. | $64.01 | -8.92% |
| 2027 Sep. | $58.94 | -7.92% |
| 2027 Oct. | $58.92 | -0.03% |
| 2027 Nov. | $64.75 | 9.89% |
| 2027 Dec. | $71.24 | 10.02% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $71.57 | 0.46% |
| 2028 Feb. | $65.79 | -8.06% |
| 2028 Mar. | $60.16 | -8.57% |
| 2028 Apr. | $58.25 | -3.18% |
| 2028 May. | $62.76 | 7.74% |
| 2028 Jun. | $69.62 | 10.94% |
| 2028 Jul. | $72.57 | 4.24% |
| 2028 Aug. | $67.68 | -6.74% |
| 2028 Sep. | $61.57 | -9.03% |
| 2028 Oct. | $57.99 | -5.81% |
| 2028 Nov. | $60.78 | 4.80% |
| 2028 Dec. | $67.59 | 11.20% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $72.72 | 7.59% |
| 2029 Feb. | $69.66 | -4.20% |
| 2029 Mar. | $63.46 | -8.91% |
| 2029 Apr. | $58.69 | -7.51% |
| 2029 May. | $59.28 | 1.01% |
| 2029 Jun. | $65.38 | 10.28% |
| 2029 Jul. | $71.63 | 9.57% |
| 2029 Aug. | $70.98 | -0.92% |
| 2029 Sep. | $65.04 | -8.36% |
| 2029 Oct. | $59.67 | -8.27% |
| 2029 Nov. | $58.60 | -1.78% |
| 2029 Dec. | $63.69 | 8.68% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $70.32 | 10.40% |
| 2030 Feb. | $71.90 | 2.26% |
| 2030 Mar. | $66.55 | -7.44% |
| 2030 Apr. | $60.68 | -8.82% |
| 2030 May. | $58.10 | -4.25% |
| 2030 Jun. | $61.99 | 6.70% |
| 2030 Jul. | $68.75 | 10.91% |
| 2030 Aug. | $72.60 | 5.59% |
| 2030 Sep. | $68.41 | -5.76% |
| 2030 Oct. | $62.23 | -9.04% |
| 2030 Nov. | $58.13 | -6.59% |
| 2030 Dec. | $60.15 | 3.47% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $66.73 | 10.94% |
| 2031 Feb. | $72.29 | 8.34% |
| 2031 Mar. | $70.19 | -2.90% |
| 2031 Apr. | $64.09 | -8.69% |
| 2031 May. | $59.04 | -7.89% |
| 2031 Jun. | $58.91 | -0.21% |
| 2031 Jul. | $64.64 | 9.73% |
| 2031 Aug. | $71.10 | 9.99% |
| 2031 Sep. | $71.37 | 0.39% |
| 2031 Oct. | $65.62 | -8.06% |
| 2031 Nov. | $60.01 | -8.55% |
| 2031 Dec. | $58.30 | -2.85% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $62.99 | 8.05% |
| 2032 Feb. | $69.72 | 10.68% |
| 2032 Mar. | $72.26 | 3.65% |
| 2032 Apr. | $67.24 | -6.95% |
| 2032 May. | $61.16 | -9.04% |
| 2032 Jun. | $57.91 | -5.32% |
| 2032 Jul. | $61.19 | 5.66% |
| 2032 Aug. | $67.98 | 11.09% |
| 2032 Sep. | $72.62 | 6.83% |
| 2032 Oct. | $69.16 | -4.77% |
| 2032 Nov. | $62.95 | -8.98% |
| 2032 Dec. | $58.39 | -7.25% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $59.53 | 1.95% |
| 2033 Feb. | $65.84 | 10.61% |
| 2033 Mar. | $71.84 | 9.12% |
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2023 Apr. is $82.1371386004321 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2024 Mar. is $62.4241950572927 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2027 Mar. is $57.6230086694048 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2028 Mar. is $60.1578283196516 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2032 Mar. is $72.2648625716857 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to Tudal, the BioMarin Pharmaceutical stock price forecast for 2033 Mar. is $71.8397029271231
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go DOWN . Therefore, Tudal would say that BioMarin Pharmaceutical (BMRN) stock is overvalued.
Will BioMarin Pharmaceutical stock price go up?
No. The BioMarin Pharmaceutical stock price forecast for 2024 Mar. is $62.4241950572927
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2023-03-24 is $90.7399978637695 and forecast for 2024 Mar. is $62.42, BioMarin Pharmaceutical stock is not a good 1 year investment.